Product Program year 2025 Source: CMS Open Payments

Bronchoscope

Device Bronchoscope

Open in the dashboard

General payments

$201,500

83 payments

Research payments

$0

0 payments

Through program year 2025, $201,500 in general payments and $0 in research payments were reported against Bronchoscope (Bronchoscope).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $77,975 43
2024 General $93,987 24
2023 General $8,525 8
2022 General $7,600 7
2021 General $13,414 1

Breakdown

Who paid General payments · program years 2021–2025
  1. Verathon Inc. $201,500 83 payments
Top recipients General payments · program year 2025
  1. Mark Ramzy Critical Care Medicine · West Orange, NJ $10,500 13% · 1 payment
  2. Jeffrey Thiboutot Internal Medicine · Baltimore, MD $9,250 12% · 1 payment
  3. Adrienne Laury Otolaryngology · Bellevue, WA $4,500 6% · 1 payment
  4. James Copeland Pulmonary Disease · Longview, WA $4,200 5% · 1 payment
  5. Radha Agrawal Pulmonary Disease · Bellevue, WA $2,250 3% · 1 payment

The top 5 of 43 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Otolaryngology $21,800 28% · 11 practitioners
  2. Pulmonary Disease Internal Medicine $14,650 19% · 9 practitioners
  3. Critical Care Medicine Internal Medicine $11,800 15% · 4 practitioners
  4. Internal Medicine $10,150 13% · 2 practitioners
  5. Neonatal-Perinatal Medicine Pediatrics $6,600 8% · 6 practitioners

The top 5 of 10 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $21,775 29% · 19 recipients
  2. New Jersey $12,050 16% · 4 recipients
  3. Washington $11,550 15% · 4 recipients
  4. Maryland $9,250 12% · 1 recipient
  5. North Carolina $8,100 11% · 5 recipients

The top 5 of 12 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

83 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record